Immuron • IMRN
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Steven Lydeamore$15.5M
Market Cap • 25/04/20241994
(há 30 anos)
2007
(17 years ago)
NASDAQ
Listagem
Melbourne
Sede • VIC5
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
IMRNSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.